RecallDepth
Class II Ongoing

Bromocriptine Mesylate Capsules, USP, 5 mg, 30 Capsules per bottle, Rx Only. Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India. Distributed by: Zydus Pharmaceuticals, Pennington, NJ 08534. NDC 68382-110-06

This recall is currently active, issued November 26, 2025. It was issued by Zydus Pharmaceuticals (Usa) Inc.

Company
Zydus Pharmaceuticals (Usa) Inc
Recall Initiated
October 23, 2025
Posted
November 26, 2025
Recall Number
D-0159-2026
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
36,624 bottles
Firm Location
Pennington, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Impurities/Degradation Specifications: Out of Specification (OOS) result reported for 2- Bromoergine impurity of Bromocriptine Mesylate Capsules.

Distribution

Nationwide in the USA

Lot / Code Info

Lot #: M313934, M313935, M315615, Exp. Date Nov 2025; M316809 , Exp. Date Dec-25; M405765, M405763, M405764, Exp. Date Apr-26; M414999, M414241, M414307, M414305, Exp. Date Oct-26

More recalls by Zydus Pharmaceuticals (Usa) Inc

View all recalls by this company →

Other recent Class II Drug recalls